L. Maxwell

发表

Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology

P. Tugwell, M. D. de Wit, J. Singh, 2019, The Journal of Rheumatology.

Adverse effects of biologics: a network meta-analysis and Cochrane overview.

G. Guyatt, P. Tugwell, J. Singh, 2011, The Cochrane database of systematic reviews.

Harmonizing Pain Outcome Measures: Results of the Pre-OMERACT Meeting on Partnerships for Consensus on Patient-important Pain Outcome Domains Between the Cochrane Musculoskeletal Group and OMERACT

P. Tugwell, J. Singh, V. Strand, 2015, The Journal of Rheumatology.

Update of Strategies to Translate Evidence from Cochrane Musculoskeletal Group Systematic Reviews for Use by Various Audiences

P. Tugwell, V. Welch, T. Rader, 2014, The Journal of Rheumatology.

Etanercept for the treatment of rheumatoid arthritis.

P. Tugwell, G. Wells, A. Lethaby, 2013, The Cochrane database of systematic reviews.

OP0071 Risk of Cancer, Serious Lung Infections and Death with Biologics: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials (RCTS)

P. Tugwell, G. Wells, L. Maxwell, 2013 .

Method guidelines for Cochrane Musculoskeletal Group systematic reviews.

P. Tugwell, R. Buchbinder, G. Wells, 2006, The Journal of rheumatology.

Reviews: Recommendations from an OMERACT 12 Workshop Optimal Strategies for Reporting Pain in Clinical Trials and Systematic

M. Suarez‐Almazor, P. Tugwell, M. Dougados, 2015 .

Roland-Morris Disability Questionnaire and Oswestry Disability Index: Which Has Better Measurement Properties for Measuring Physical Functioning in Nonspecific Low Back Pain? Systematic Review and Meta-Analysis

P. Tugwell, C. Terwee, R. Ostelo, 2016, Physical Therapy.

Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group

Christie M. Bartels, P. Tugwell, V. Welch, 2017, The Journal of Rheumatology.

Composite outcomes at OMERACT: Multi-outcome domains and composite outcome domains.

P. Tugwell, F. Guillemin, L. March, 2021, Seminars in arthritis and rheumatism.

Identifying patient-important outcomes in medication-assisted treatment for opioid use disorder patients: a systematic review protocol

P. Tugwell, D. Rice, D. Beaton, 2018, BMJ Open.

Some Cochrane risk-of-bias items are not important in osteoarthritis trials: a meta-epidemiological study based on Cochrane reviews.

P. Tugwell, T. Rader, I. Boutron, 2017, Journal of clinical epidemiology.

Drug interventions versus placebo for the treatment of Raynaud’s phenomenon: generic protocol

G. Wells, L. Maxwell, Elizabeth Tanjong Ghogomu, 2022, Cochrane Database of Systematic Reviews.

Dialogue on Developing Consensus on Measurement and Presentation of Patient-important Outcomes, Using Pain Outcomes as an Exemplar, in Systematic Reviews: A Preconference Meeting at OMERACT 12

P. Tugwell, C. Terwee, P. Williamson, 2015, The Journal of Rheumatology.

Disease-modifying anti-rheumatic drugs for rheumatoid arthritis: a systematic review and network meta-analysis

P. Tugwell, E. Akl, R. Buchbinder, 2020 .

When and how to replicate systematic reviews

J. Ioannidis, P. Tugwell, V. Welch, 2020 .

PROTOCOL: When and how to replicate systematic reviews

J. Ioannidis, P. Tugwell, V. Welch, 2020, Campbell systematic reviews.

Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.

M. Suarez‐Almazor, P. Tugwell, J. Singh, 2017, The Cochrane database of systematic reviews.

The Journal of Rheumatology OMERACT Delphi Survey and Consensus Meeting Shared Decision-making Interventions in Rheumatology : Results from an Toward the Development of a Core Set of Outcome Domains to Assess

Janet, P. Tugwell, V. Welch, 2017 .

Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting

Linda C. Li, M. Suarez‐Almazor, P. Tugwell, 2017, The Journal of Rheumatology.

Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach.

Linda C. Li, M. Suarez‐Almazor, P. Tugwell, 2021, Seminars in arthritis and rheumatism.

Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-reported Outcome Measures

P. Tugwell, V. Welch, J. Jull, 2015, The Journal of Rheumatology.

Determining the minimal clinically important differences in activity, fatigue, and sleep quality in patients with rheumatoid arthritis.

P. Tugwell, Tracy T Li, G. Wells, 2007, The Journal of rheumatology.

Introduction

P. Tugwell, L. March, P. Brooks, 2019, The Journal of Rheumatology.

Protocol for the development of guidance for stakeholder engagement in health and healthcare guideline development and implementation

P. Tugwell, V. Welch, J. Jull, 2020, Systematic Reviews.

The Journal of Rheumatology MethodologyInstrument Selection Using the OMERACT Filter 2.1: The OMERACT

J. Singh, L. March, D. Beaton, 2020 .

Drug interventions versus placebo for the treatment of Raynaud’s phenomenon: generic protocol

P. Tugwell, G. Wells, L. Maxwell, 2015, Cochrane Database of Systematic Reviews.

Consensus Building in OMERACT: Recommendations for Use of the Delphi for Core Outcome Set Development

P. Tugwell, M. D. de Wit, L. March, 2019, The Journal of Rheumatology.

Physicians' vs patients' global assessments of disease activity in rheumatology and musculoskeletal trials: A meta-research project with focus on reasons for discrepancies.

P. Tugwell, D. Beaton, V. Strand, 2022, Seminars in arthritis and rheumatism.

Cochrane and Campbell Collaborations, and health equity

P. Tugwell, E. Kristjansson, M. Petticrew, 2006, The Lancet.

Knowledge transfer to clinicians and consumers by the Cochrane Musculoskeletal Group.

P. Tugwell, R. Buchbinder, A. O'Connor, 2006, The Journal of rheumatology.

Glucosamine therapy for treating osteoarthritis (Review)

M. Hochberg, G. Wells, B. Shea, 2005 .

The REPRISE project: protocol for an evaluation of REProducibility and Replicability In Syntheses of Evidence

Neal R Haddaway, P. Tugwell, D. Nunan, 2021, Systematic Reviews.

Chondroitin for osteoarthritis.

R. MacDonald, J. Singh, L. Maxwell, 2015, The Cochrane database of systematic reviews.

Glucosamine therapy for treating osteoarthritis.

V. Welch, M. Hochberg, G. Wells, 2005, The Cochrane database of systematic reviews.

Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report

M. D. de Wit, L. Coates, D. Gladman, 2019, The Journal of Rheumatology.

Abatacept for Rheumatoid Arthritis: A Cochrane Systematic Review

J. Singh, L. Maxwell, 2010, The Journal of Rheumatology.

Measurement Properties of Visual Analogue Scale, Numeric Rating Scale, and Pain Severity Subscale of the Brief Pain Inventory in Patients With Low Back Pain: A Systematic Review.

P. Tugwell, C. Terwee, R. Ostelo, 2019, The journal of pain : official journal of the American Pain Society.

Optimal Strategies for Reporting Pain in Clinical Trials and Systematic Reviews: Recommendations from an OMERACT 12 Workshop

G. Guyatt, M. Suarez‐Almazor, P. Tugwell, 2015, The Journal of Rheumatology.

TNF-alpha inhibitors for ankylosing spondylitis.

P. Tugwell, Maria Benkhalti Jandu, J. Singh, 2015, The Cochrane database of systematic reviews.

Current State of Reporting Pain Outcomes in Cochrane Reviews of Chronic Musculoskeletal Pain Conditions and Considerations for an OMERACT Research Agenda

P. Tugwell, N. Goel, C. Terwee, 2015, The Journal of Rheumatology.

Optimal Strategies for Reporting Pain in Clinical Trials and Systematic Reviews: Recommendations from a 2014 OMERACT Workshop

G. Guyatt, M. Suarez‐Almazor, P. Tugwell, 2014 .

Calcium channel blockers for primary and secondary Raynaud's phenomenon.

P. Tugwell, G. Wells, L. Maxwell, 2017, The Cochrane database of systematic reviews.

Diacerein for osteoarthritis.

C. R. Macedo, L. Maxwell, V. Fernandes Moça Trevisani, 2014, The Cochrane database of systematic reviews.

Assessing the effect of interventions for axial spondyloarthritis according to the endorsed ASAS/OMERACT core outcome set: a meta-research study of trials included in Cochrane reviews

P. Tugwell, M. D. de Wit, M. Boers, 2020, Arthritis Research & Therapy.

Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.

M. Suarez‐Almazor, P. Tugwell, J. Singh, 2017, The Cochrane database of systematic reviews.

Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.

P. Tugwell, J. Singh, G. Wells, 2016, The Cochrane database of systematic reviews.

The evolution of instrument selection for inclusion in core outcome sets at OMERACT: Filter 2.2.

P. Tugwell, D. Beaton, M. Boers, 2021, Seminars in arthritis and rheumatism.

OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies

P. Tugwell, M. D. de Wit, J. Singh, 2019, The Journal of Rheumatology.

The OMERACT Stepwise Approach to Select and Develop Imaging Outcome Measurement Instruments: The Musculoskeletal Ultrasound Example

A. Iagnocco, E. Naredo, D. Beaton, 2019, The Journal of Rheumatology.

Assessment of Intra- and Inter-individual Variability of Outcome Measures in Ankylosing Spondylitis and the Efficacy and Adverse Effects of Anti-TNF Therapy

L. Maxwell, 2011 .

When to replicate systematic reviews of interventions: consensus checklist

David B. Wilson, J. Ioannidis, P. Tugwell, 2020, BMJ.

Consensus on the Need for a Hierarchical List of Patient-reported Pain Outcomes for Metaanalyses of Knee Osteoarthritis Trials: An OMERACT Objective

P. Tugwell, N. Goel, C. Terwee, 2015, The Journal of Rheumatology.

Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group.

Jin Kyun Park, D. Beaton, J. Park, 2022, Seminars in arthritis and rheumatism.

Is health equity considered in systematic reviews of the Cochrane Musculoskeletal Group?

M. Suarez‐Almazor, P. Tugwell, V. Welch, 2008, Arthritis and rheumatism.

Improving domain definition and outcome instrument selection: Lessons learned for OMERACT from imaging.

Win Min Oo, M. D. de Wit, D. Beaton, 2021, Seminars in arthritis and rheumatism.

Are we measuring the right function outcomes for older adults in reviews by the Cochrane Musculoskeletal Group?

P. Tugwell, V. Welch, L. Maxwell, 2021, Seminars in arthritis and rheumatism.

Updated Method Guidelines for Cochrane Musculoskeletal Group Systematic Reviews and Metaanalyses

P. Tugwell, T. Rader, J. Singh, 2014, The Journal of Rheumatology.

Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 process.

D. Beaton, V. Strand, E. Matteson, 2021, Seminars in arthritis and rheumatism.

Systematic reviewers' perspectives on replication of systematic reviews: A survey

D. Nunan, D. Moher, M. Page, 2023, Cochrane Evidence Synthesis and Methods.

Abatacept for rheumatoid arthritis.

Jasvinder A Singh, J. Singh, L. Maxwell, 2009, The Cochrane database of systematic reviews.

Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis

P. Tugwell, P. Tugwell, G. Wells, 2007, Annals of the rheumatic diseases.

Developing a core outcome set for foot and ankle disorders in rheumatic and musculoskeletal diseases: A scoping review and report from the OMERACT 2022 foot and ankle special interest group session.

H. Menz, D. Beaton, M. Hannan, 2023, Seminars in arthritis and rheumatism.

Developing an Outcome Measures in Rheumatology (OMERACT) Core set of Outcome Measures for FOot and ankle disorders in RheumaTic and musculoskeletal diseases (COMFORT): core domain set study protocol

P. Tugwell, H. Menz, D. Beaton, 2023, Trials.

“One more time”: why replicating some syntheses of evidence relevant to COVID-19 makes sense

Neal R Haddaway, P. Tugwell, V. Welch, 2020, Journal of Clinical Epidemiology.

Core outcome measurement instrument selection for physical function in hand osteoarthritis using the OMERACT Filter 2.1 process.

D. Beaton, D. M. van der Heijde, C. Hill, 2021, Seminars in arthritis and rheumatism.

OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions

Linda C. Li, M. Suarez‐Almazor, P. Tugwell, 2019, The Journal of Rheumatology.

Development of a core domain set of outcomes for shared decision making interventions: An OMERACT white paper with stakeholders’ input

Linda C. Li, M. Suarez‐Almazor, J. Jull, 2019 .

Acetaminophen for osteoarthritis.

M. Hochberg, G. Wells, L. Maxwell, 2003, The Cochrane database of systematic reviews.

Systematic reviews from the Cochrane Musculoskeletal Group.

P. Tugwell, R. Buchbinder, L. Maxwell, 2006, The Journal of the Canadian Chiropractic Association.

Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology

P. Tugwell, M. D. de Wit, J. Singh, 2019, The Journal of Rheumatology.

Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets

P. Tugwell, M. D. de Wit, J. Singh, 2017, Journal of Rheumatology.

Colchicine for acute gout.

L. Maxwell, N. Schlesinger, M. Catton, 2006, The Cochrane database of systematic reviews.

Systematic reviewers' perspectives on sharing review data, analytic code, and other materials: A survey

D. Nunan, D. Moher, M. Page, 2023, Cochrane Evidence Synthesis and Methods.

Assessing bias in osteoarthritis trials included in Cochrane reviews: protocol for a meta-epidemiological study

P. Tugwell, T. Rader, I. Boutron, 2014, BMJ Open.

Controversy and Debate Series on Core Outcome Sets. Paper 2: Debate on Paper 1 from the perspective of OMERACT [Outcome Measures in Rheumatology]

D. Beaton, L. Maxwell, 2020 .

Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets

P. Tugwell, M. D. de Wit, J. Singh, 2017, The Journal of Rheumatology.

OMERACT 2020: A virtual (R)evolution.

P. Tugwell, B. Shea, J. Singh, 2021, Seminars in arthritis and rheumatism.

Acetaminophen for osteoarthritis.

M. Hochberg, G. Wells, L. Maxwell, 2006, The Cochrane database of systematic reviews.

Protocol for the development of guidance for collaborator and partner engagement in health care evidence syntheses

J. Jull, J. Petkovic, K. Pottie, 2023, Systematic Reviews.

Abatacept for Rheumatoid Arthritis: A Cochrane Systematic Review

J. Singh, L. Maxwell, 2010, The Journal of Rheumatology.

Optimal Strategies for Reporting Pain in Clinical Trials and Systematic Reviews: Recommendations from an OMERACT 12 Workshop

G. Guyatt, M. Suarez‐Almazor, P. Tugwell, 2015, The Journal of Rheumatology.

Tramadol for osteoarthritis

L. Maxwell, A. Rutjes, P. Tugwell, 2006 .

Dialogue on Developing Consensus on Measurement and Presentation of Patient-important Outcomes, Using Pain Outcomes as an Exemplar, in Systematic Reviews: A Preconference Meeting at OMERACT 12

P. Tugwell, C. Terwee, P. Williamson, 2015, The Journal of Rheumatology.

Etanercept for the treatment of rheumatoid arthritis.

P. Tugwell, G. Wells, A. Lethaby, 2013, The Cochrane database of systematic reviews.

Tramadol for osteoarthritis

L. Maxwell, A. Rutjes, P. Tugwell, 2006 .

Phosphodiesterase 5 inhibitors (PDE5i) for the treatment of Raynaud's phenomenon.

L. Maxwell, Elizabeth Tanjong Ghogomu, P. Tugwell, 2023, The Cochrane database of systematic reviews.

Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group

P. Tugwell, V. Welch, J. Jull, 2017, The Journal of Rheumatology.